Molecular dynamics analysis of N-acetyl-D-glucosamine against specific SARS-CoV-2’s pathogenicity factors

The causative agent of the pandemic identified as SARS-CoV-2 leads to a severe respiratory illness similar to SARS and MERS with fever, cough, and shortness of breath symptoms and severe cases that can often be fatal. In our study, we report our findings based on molecular docking analysis which could be the new effective way for controlling the SARS-CoV-2 virus and additionally, another manipulative possibilities involving the mimicking of immune system as occurred during the bacterial cell recognition system. For this purpose, we performed molecular docking using computational biology techniques on several SARS-CoV-2 proteins that are responsible for its pathogenicity against N-acetyl-D-glucosamine. A similar molecular dynamics analysis has been carried out on both SARS-CoV-2 and anti-Staphylococcus aureus neutralizing antibodies to establish the potential of N-acetyl-D-glucosamine which likely induces the immune response against the virus. The results of molecular dynamic analysis have confirmed that SARS-CoV-2 spike receptor-binding domain (PDB: 6M0J), RNA-binding domain of nucleocapsid phosphoprotein (PDB: 6WKP), refusion SARS-CoV-2 S ectodomain trimer (PDB: 6X79), and main protease 3clpro at room temperature (PDB: 7JVZ) could bind with N-acetyl-D-glucosamine that these proteins play an important role in SARS-CoV-2’s infection and evade the immune system. Moreover, our molecular docking analysis has supported a strong protein-ligand interaction of N-acetyl-D-glucosamine with these selected proteins. Furthermore, computational analysis against the D614G mutant of the virus has shown that N-acetyl-D-glucosamine affinity and its binding potential were not affected by the mutations occurring in the virus’ receptor binding domain. The analysis on the affinity of N-acetyl-D-glucosamine towards human antibodies has shown that it could potentially bind to both SARS-CoV-2 proteins and antibodies based on our predictive modelling work. Our results confirmed that N-acetyl-D-glucosamine holds the potential to inhibit several SARS-CoV-2 proteins as well as induce an immune response against the virus in the host. © 2021 Baysal et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Baysal Ö.1 , Ghafoor N.A.1 , Silme R.S.2 , Ignatov A.N. 3 , Kniazeva V.4
Public Library of Science
Номер выпуска
5 May
  • 1 Faculty of Science, Department of Molecular Biology and Genetics, Molecular Microbiology Unit, Muğla Sıtkı Koçman University, Menteşe-Muğla, Turkey
  • 2 Center for Research and Practice in Biotechnology and Genetic Engineering, Istanbul University, Istanbul, Turkey
  • 3 Federal State Autonomous Educational Institution, People’s Friendship University of Russia, Moscow, Russian Federation
  • 4 Institute of Biophysics and Cell Engineering of the, National Academy of Sciences of Belarus, Minsk, Belarus
Ключевые слова
n acetylglucosamine; neutralizing antibody; viral protein; virulence factor; virus antibody; chemistry; human; immunology; molecular dynamics; pathogenicity; Acetylglucosamine; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Humans; Molecular Dynamics Simulation; SARS-CoV-2; Viral Proteins; Virulence Factors
Дата создания
Дата изменения
Постоянная ссылка

Другие записи

Blagonravov M.L., Sklifasovskaya A.P., Demurov E.A., Karimov A.A.
Бюллетень экспериментальной биологии и медицины Клеточные технологии в биологии и медицине. New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук. Том 171. 2021. С. 23-27